GUPTA, V. K.; GIRI, R.; AGRAWAL, S. Dipeptidyl peptidase-4 inhibitor (teneligliptin) significantly reduces liver fat content and delays progression of non-alcoholic steatohepatitis in type 2 diabetes mellitus patients. International Journal of Advances in Medicine, [S. l.], v. 8, n. 12, p. 1817–1820, 2021. DOI: 10.18203/2349-3933.ijam20214516. Disponível em: https://www.ijmedicine.com/index.php/ijam/article/view/3257. Acesso em: 13 oct. 2025.